Polyvalent vaccines: High-maintenance heroes

Safety concerns derail dengue vaccination program

(2017) Dennis Normile   SCIENCE

A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques

(2016) Sujin Lee et al.   Nature Communications

Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine

(2015) H. Seitz et al.   Cancer Prevention Research

Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?

(2015) Stephen S. Whitehead   Expert Review of Vaccines

Dengue vaccines: Challenges, development, current status and prospects

(2015) L Dar et al.   Indian Journal of Medical Microbiology

Updated, augmented vaccines compete with original antigenic sin

(2015) Shraddha Chakradhar   NATURE MEDICINE

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Challenges in developing a cross-serotype rhinovirus vaccine

(2015) Nicholas Glanville et al.   Current Opinion in Virology

Fatal Disseminated Cryptococcosis Resembling Miliary Tuberculosis in a Patient with HIV Infection

(2014) Masafumi Shimoda et al.   INTERNAL MEDICINE

Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins

(2014) Jon Cuccui et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types

(2013) C. L. McIntyre et al.   JOURNAL OF GENERAL VIROLOGY

Vaccine production, distribution, access, and uptake

(2011) Jon Smith et al.   LANCET

Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation

(2010) J. Edlmayr et al.   EUROPEAN RESPIRATORY JOURNAL

The ABCs of Rhinoviruses, Wheezing, and Asthma

(2010) J. E. Gern   JOURNAL OF VIROLOGY

Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development

(2010) Rene Reinert et al.   VACCINE

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

(2009) Subhashini Jagu et al.   JNCI-Journal of the National Cancer Institute

Vaccination greatly reduces disease, disability, death and inequity worldwide

(2008) FE Andre et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION